Published by Josh White on 11th December 2025
(Sharecast News) - Eli Lilly reported the first successful phase three results for retatrutide, its experimental once-weekly 'triple agonist' drug, showing unprecedented weight loss alongside major improvements in knee osteoarthritis pain.
URL: http://www.digitallook.com/dl/news/story/35557387/...